Atea Pharmaceuticals (NASDAQ:AVIR) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.44) by 77.27 percent. This is a 70.59 percent increase over losses of $(0.34) per share from the same period last year.
What’s Going On With Nvidia Stock? Bill & Melinda Gates Foundation Buy $4M Stake
The Bill & Melinda Gates Foundation Trust, which manages the Gates Foundation's endowment, made its first-ever purchase of Nvidia Corp (NYSE: NVDA) shares, acquiring approximately 9,200 shares valued
